HROW Q2 2021 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q2 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$18M+125.0% YoY

Gross Profit

$14M75.6% margin

Operating Income

$4M23.0% margin

Net Income

-$2M-13.7% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

+17.4%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$4M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$107M

Total Liabilities

$84M

Stockholders' Equity

$23M

Cash & Equivalents

$73M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$8M	+125.0%
Gross Profit	$14M	$5M	+182.5%
Operating Income	$4M	-$3M	+229.9%
Net Income	-$2M	-$237,000	-945.6%

Revenue Segments

Other Revenues

$837,000100%